OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00400059

Lotte Fine Chemical Co Ltd

Diversified ChemicalsVerified

Lotte Fine Chemical maintains a strong liquidity position, with a current ratio of 4.25, indicating the company can easily cover its short-term obligations. The company holds KRW 172.04 billion in cash and equivalents, and its long-term debt is relatively low at KRW 67.58 billion, resulting in a debt-to-equity ratio of 0.03. This conservative capital structure supports financial flexibility and reduces refinancing risk. Profitability metrics show a return on equity (ROE) of 4.36% and a return on assets (ROA) of 3.86%, which are in line with the industry's preferred metrics for diversified chemical firms. The company's operating income of KRW 66.31 billion and net income of KRW 106.09 billion reflect solid operational performance, though the gross profit margin of 11.72% (KRW 205.46 billion on KRW 1.75 trillion in revenue) suggests moderate pricing power in its core markets. The company's revenue is concentrated in a few key segments, with the majority derived from its chemical intermediates and polymers business. Geographically, the firm is heavily exposed to the Korean domestic market, with limited international diversification. This concentration increases vulnerability to local economic and regulatory shifts. Looking ahead, the company is projected to maintain stable revenue growth, with a modest increase in the current fiscal year and a slightly higher growth rate in the following year. The free cash flow remains negative at KRW -36.87 billion, primarily due to significant capital expenditures of KRW -271.57 billion, which suggests ongoing investment in production capacity and infrastructure. Risk factors include the potential for regulatory changes in the chemical industry and the volatility of raw material prices. The company has no immediate filing-based liquidity or dilution flags, and the risk of near-term equity dilution is low. However, the high capital expenditures may lead to increased leverage in the future if not offset by operating cash flow. Recent events include the release of the latest financial report, which showed strong operating performance and a conservative capital structure. Analysts have provided a mean price target of KRW 71,000, with a median of KRW 71,000, and a mean recommendation of 1.43, indicating a generally positive outlook from the investment community.

30-day price · 004000+8450.00 (+18.1%)
Low$46100.00High$71800.00Close$55200.00As of15 May, 00:00 UTC
Profile
CompanyLotte Fine Chemical Co Ltd
Ticker004000.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Lotte Fine Chemical Co Ltd is a diversified chemicals company that produces and sells a range of chemical products, including intermediates, polymers, and specialty chemicals, primarily serving the plastics, textiles, and pharmaceutical industries.

Classification. Lotte Fine Chemical is classified under the Basic Materials economic sector, within the Chemicals business sector, and the Diversified Chemicals industry, with a classification confidence of 0.92.

Lotte Fine Chemical maintains a strong liquidity position, with a current ratio of 4.25, indicating the company can easily cover its short-term obligations. The company holds KRW 172.04 billion in cash and equivalents, and its long-term debt is relatively low at KRW 67.58 billion, resulting in a debt-to-equity ratio of 0.03. This conservative capital structure supports financial flexibility and reduces refinancing risk. Profitability metrics show a return on equity (ROE) of 4.36% and a return on assets (ROA) of 3.86%, which are in line with the industry's preferred metrics for diversified chemical firms. The company's operating income of KRW 66.31 billion and net income of KRW 106.09 billion reflect solid operational performance, though the gross profit margin of 11.72% (KRW 205.46 billion on KRW 1.75 trillion in revenue) suggests moderate pricing power in its core markets. The company's revenue is concentrated in a few key segments, with the majority derived from its chemical intermediates and polymers business. Geographically, the firm is heavily exposed to the Korean domestic market, with limited international diversification. This concentration increases vulnerability to local economic and regulatory shifts. Looking ahead, the company is projected to maintain stable revenue growth, with a modest increase in the current fiscal year and a slightly higher growth rate in the following year. The free cash flow remains negative at KRW -36.87 billion, primarily due to significant capital expenditures of KRW -271.57 billion, which suggests ongoing investment in production capacity and infrastructure. Risk factors include the potential for regulatory changes in the chemical industry and the volatility of raw material prices. The company has no immediate filing-based liquidity or dilution flags, and the risk of near-term equity dilution is low. However, the high capital expenditures may lead to increased leverage in the future if not offset by operating cash flow. Recent events include the release of the latest financial report, which showed strong operating performance and a conservative capital structure. Analysts have provided a mean price target of KRW 71,000, with a median of KRW 71,000, and a mean recommendation of 1.43, indicating a generally positive outlook from the investment community.
Key takeaways
  • Lotte Fine Chemical has a strong liquidity position with a current ratio of 4.25 and a low debt-to-equity ratio of 0.03.
  • The company's ROE of 4.36% and ROA of 3.86% indicate solid profitability, though not exceptional for the industry.
  • Revenue is concentrated in a few key segments and the domestic Korean market, increasing exposure to local economic conditions.
  • Analysts project stable revenue growth and a positive outlook, with a mean price target of KRW 71,000.
  • The company's high capital expenditures may lead to increased leverage in the future if not offset by operating cash flow.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$1.75T
Gross profit$205.46B
Operating income$66.31B
Net income$106.09B
R&D
SG&A
D&A
SBC
Operating cash flow$300.89B
CapEx-$271.57B
Free cash flow-$36.87B
Total assets$2.75T
Total liabilities$310.43B
Total equity$2.44T
Cash & equivalents$172.04B
Long-term debt$67.58B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.75T$66.31B$106.09B-$36.87B
FY-1$1.67T$48.61B$36.38B-$53.44B
FY-2$1.77T$154.74B$182.03B$131.36B
FY-3
FY-4$1.78T$241.02B$585.46B$556.46B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$2.75T$2.44T$172.04B
FY-1$2.71T$2.37T$298.48B
FY-2$2.68T$2.38T$460.89B
FY-3
FY-4$2.72T$2.20T$228.81B
PeriodOCFCapExFCFSBC
FY0$300.89B-$271.57B-$36.87B
FY-1$160.04B-$198.12B-$53.44B
FY-2$224.13B-$99.98B$131.36B
FY-3
FY-4$308.52B-$111.83B$556.46B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$439.06B$17.01B$26.97B-$75.59B
FQ-1
FQ-2$424.67B$8.71B$15.52B$7.98B
FQ-3$445.59B$18.78B$28.39B$25.85B
FQ-4$428.61B$10.40B-$18.75B-$17.10B
FQ-5$420.41B$10.33B-$71.56B-$102.28B
FQ-6$422.07B$17.11B$43.27B$49.22B
FQ-7$399.44B$10.77B$83.42B$67.65B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$2.75T$2.44T$172.04B
FQ-1
FQ-2$2.73T$2.38T$430.71B
FQ-3$2.78T$2.36T$387.26B
FQ-4$2.71T$2.37T$298.48B
FQ-5$2.78T$2.39T$363.96B
FQ-6$2.85T$2.46T$450.39B
FQ-7$2.84T$2.42T$408.18B
PeriodOCFCapExFCFSBC
FQ0$300.89B-$271.57B-$75.59B
FQ-1
FQ-2$200.84B-$88.15B$7.98B
FQ-3$95.13B-$41.04B$25.85B
FQ-4$160.04B-$198.12B-$17.10B
FQ-5$150.40B-$159.16B-$102.28B
FQ-6$107.64B-$87.37B$49.22B
FQ-7$72.49B-$53.07B$67.65B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.44T
Net cash$104.46B
Current ratio4.2
Debt/Equity0.0
ROA3.9%
ROE4.4%
Cash conversion2.8%
CapEx/Revenue-15.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
Metric004000Activity
Op margin3.8%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin6.1%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin11.7%12.9% medp25 12.9% · p75 12.9%bottom quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-15.5%-7.1% medp25 -12.7% · p75 -4.4%bottom quartile
Debt / equity3.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
Mean price target71,000.00 KRW
Median price target71,000.00 KRW
High price target86,000.00 KRW
Low price target56,000.00 KRW
Mean recommendation1.43 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate6,661.00 KRW
Last actual EPS4,165.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:11 UTCJob: 7ec8f01a